Form 4 for EVMN Evommune, Inc.

Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001678620-25-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-11-12	2025-11-07	EVMN	Bauer Eugene	Chief Medical Off, Dir	C - Cnv Deriv	—	+25.8K	272.3K	+10%	—
DM	2025-11-12	2025-11-07	EVMN	Bauer Eugene	Chief Medical Off, Dir	C - Cnv Deriv	—	-218.9K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-07	C	A	25,812	—	272,296	D	—	—	(F1) Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date. (F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
2	Derivative	Series Seed Preferred Stock	2025-11-07	C	D	206,355	—	0	D	— · — to —	24,225 Common Stock	(F1) Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-8.518 basis and had no expiration date.
3	Derivative	Series B Preferred Stock	2025-11-07	C	D	12,500	—	0	D	— · — to —	1,587 Common Stock	(F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date.